FDA Approves First COVID-19 Antiviral Treatment That May Increase Testing Volumes for Clinical Laboratories
Three types of clinical laboratory testing support were stipulated with first FDA approval of antiviral drug for COVID-19 treatment.
Day: November 2, 2020